Expression of B7-H1 on peripheral myeloid dendritic cells in patients with HIV infection and its correlation with diseases progression

National Medical Journal of China

Volumn 90, Issue 9, 2010, Pages 588-592

  Wang, Xi Cheng ^a   Fan, Yi Shan ^a   Zhou, Zeng Quan ^a   Li, Hui Qin ^a   Zhang, Zheng ^b   Zhang, Tong ^b   Wang, Li ^a   Yang, Xin Ping ^a   Mao, Lin ^a   Xie, Rong Hui ^a   Lei, Su Yun ^a   Wu, Hao ^b   Wang, Fu Sheng ^b  

^a AIDS Care Center (YNACC)   (China)

^b NONE

Author keywords

Acquired immunodeficiency syndrome; Dendritic cells; HIV 1

Indexed keywords

PROGRAMMED DEATH 1 LIGAND 1; CD274 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ANTIGEN EXPRESSION; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MYELOID DENDRITIC CELL; TREATMENT RESPONSE; UPREGULATION; VIRUS LOAD; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; BLOOD; CASE CONTROL STUDY; DENDRITIC CELL; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIGENS, CD; CASE-CONTROL STUDIES; DENDRITIC CELLS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; VIRAL LOAD; YOUNG ADULT;

EID: 84871420178     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.09.005     Document Type: Article

References (20)

1. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol, 2004, 4: 336-347.
2. Barber D L, Wherry E J, Masopust D, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature, 2006, 439: 682-687.
3. Steinman R M. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol, 1991, 9: 271-296.
4. Wu L, KewalRamani V N. Dendritic-cell interactions with HIV; infection and viral dissemination. Nat Rev Immunol, 2006, 6; 859-868.
5. 2009, 29: 751-752.
6. Chen L, Zhang Z, Chen W, et al. B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B. J Immunol, 2007, 178: 6634-6641.
7. Selenko-Gebauer N, Majdic O, Szekeres A, et al. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J Immunol, 2003, 170: 3637-3644.
8. Geng L, Jiang G, Fang Y, et al. B7-H1 expression is upregulated in peripheral blood CD14 + monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL-10 levels. J Viral Hepat, 2006, 13: 725-733.
9. 2007, 27: 1635-1637.
10. 2007, 25: 320-323.
11. Deeks S G, Walker B D. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity, 2007, 27: 406-416.
12. Trabattoni D, Saresella M, Biasin M, et al. B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. Blood, 2003, 101: 2514-2520.
13. Wang S, Chen L. Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses. Microbes Infect, 2004, 6: 759-766.
14. 2005, 21: 906-991.
15. Ge W, Ma X, Li X, et al. B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/1L-12 production and generation of Treg cells. Leuk Res, 2009, 33: 948-957.
16. Zhang J Y, Zhang Z, Wang X, et al. PD-1 up-regulation is correlated with HIV-specific memory CD8 + T-cell exhaustion in typical progressors but not in long-term nonprogressors. Blood, 2007, 109: 4671-4678.
17. Freeman G J, Long A J, Iwai Y, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med, 2000, 192: 1027-1034.
18. Wilcox R A, Feldman A L, Wada D A, et al. B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders. Blood, 2009, 114: 2149-2158.
19. Freeman G J, Wherry E J, Ahmed R, et al. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J Exp Med, 2006, 203: 2223-2227.
20. Trautmann L, Said E A, Halwani R, et al. Programmed death 1: a critical regulator of T-cell function and a strong target for immunotherapies for chronic viral infections. Curr Opin HIV AIDS, 2007, 2: 219-227.